Registration powered by Eventbrite
Contact Xconomy for event and ticket information.
Xconomy Forum: San Diego Life Sciences 2030

Xconomy Forum: San Diego Life Sciences 2030

Wednesday, March 31, 2010 from 6:00 PM - 8:30 PM (PT)

San Diego, CA


This event has ended!
View current events hosted by Xconomy


Ticket Information

Ticket Type Sales End Price Fee Quantity
Early Bird Ended $75.00 $0.00 N/A
Regular Registration Ended $95.00 $0.00 N/A
VIP Seating
Reserved seating in VIP Section. Limited to 10 tickets.
Ended $125.00 $0.00 N/A
Student Registration   more info Ended $20.00 $0.00 Sold Out
Walk-in Registration Ended $125.00 $0.00 N/A

Event Details

Tickets are transferable but not refundable.

Responding to ongoing demand, we were able to increase capacity for this Forum and re-open registration. Thank you to our event host, Biogen Idec. There are a limited number of seats available. Registration will close 1 day before the Forum.

San Diego biotech has taken its share of lumps lately, but beyond the next quarter or next year, what kind of life sciences potential really exists here? What will the San Diego life sciences landscape look like 20 years from now? Will the region have grown as a world leader in university and corporate research, venture financing, and entrepreneurial activity? Which particular fields of life sciences and healthcare will be the most vibrant? We will bring together a select group of innovators and visionaries in the heart of La Jolla for an intimate, interactive discussion of these and other key questions about the future of San Diego-area life sciences.


Welcoming Remarks:

  • John Dunn, Executive Vice President, Biogen Idec New Ventures

Panelists:

  • John Mendlein (moderator), Chairman of the Board, Fate Therapeutics
  • Paul Schimmel, Professor of Chemical Biology, The Scripps Research Institute; Cofounder or founding director of eleven biotechnology companies, of which six (Alkermes, Alnylam Pharmaceuticals, Avicena Group, Cubist Pharmaceuticals, Momenta Pharmaceuticals, Repligen Corporation) are publicly traded.
  • Dan Bradbury, President and CEO, Amylin Pharmaceuticals; Chairman of BIOCOM
  • Fred “Rusty” Gage, Professor and Vi and John Adler Chair for Research on Age-Related Neurodegenerative Diseases, Salk Institute for Biological Studies

Bonus Feature:
Meet top executives from emerging life sciences enterprises, who will provide brief introductions to their organizations.

  • Ambrx
  • Biogen Idec New Ventures
  • Helixis
  • Receptos
  • VentiRx Pharmaceuticals

Schedule:
Registration Opens: 5:15 pm
Program: 6:00 pm – 7:30 pm
Reception: 7:30 pm – 8:30 pm

Tickets are transferable but not refundable.
To inquire about press registration, email events@xconomy.com.


EVENT HOST

Biogen Idec

 

EVENT SPONSORS

Biogen Idec New Ventures


Fish & Richardson Halloran Consulting Group

 

EVENT PARTNER

BIOCOM

 

UNDERWRITERS

Alexandria Real Estate Equities · Biogen Idec
· Latham & Watkins
Science and Technology Directorate, U.S. Department of Homeland Security


PARTNERS


BIOCOM · CleanTECH San Diego · CommNexus San Diego · CONNECT
San Diego Software Industry Council · San Diego Venture Group


VENTURE CAPITAL MEMBER


Enterprise Partners Venture Group

This event organizer is using Eventbrite to provide
event ticketing and online event registration.
Contact Xconomy for event and ticket information.